Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Novartis India Ltd

NSE: NOVARTIND · BSE: 500672 · Pharmaceuticals & Biotechnology · 34 announcements

Share price
₹2,010.50
Market cap
₹4,964 Cr
Revenue (annual)
₹354.3 Cr
Net profit (annual)
₹93.18 Cr
P/E (TTM)
50.8×Sector 47.4×
Promoter holding
70.68%+0.00% QoQ
FII holding
0.15%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

16:52 IST BSE
Debt & Borrowing

Novartis India Debt & Borrowing

Novartis India Limited confirmed it does not qualify as a 'Large Corporate' for FY 2025-26 per SEBI debt-raising norms. The company reported zero outstanding long-term borrowings as of March 31, 2025. This routine regulatory disclosure indicates the company is not currently subject to mandatory incremental borrowing through debt securities.